Disclosures for "Increasing SUR1-related pathway activity with increasing injury severity in immune and neurovascular cells after murine TBI")
-
Mr. Sneiderman has nothing to disclose.
-
Dr. Xiong has nothing to disclose.
-
Dr. Rajasundaram has nothing to disclose.
-
Dr. Simon has nothing to disclose.
-
Dr. Catapano has nothing to disclose.
-
Mrs. Mihaljevic has nothing to disclose.
-
Dr. Shahjouei has nothing to disclose.
-
Dr. Raikwar has nothing to disclose.
-
Dr. Rani has nothing to disclose.
-
Miss Trivedi has nothing to disclose.
-
Mr. Rulney has nothing to disclose.
-
Dr. Winkler has nothing to disclose.
-
Ms. Miller has nothing to disclose.
-
Mr. Lim has nothing to disclose.
-
Ms. Feldman has nothing to disclose.
-
Vincent Vagni has nothing to disclose.
-
The institution of Dr. Kohanbash has received research support from NIH.
-
Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
-
Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.